Adam Bristol PhD

Adam joined Aquilo Partners in 2010. From 2007 through 2009, he was an associate at the Biotechnology Value Fund, assisting in the sourcing, evaluation and management of investments in private and public life science companies. Adam serves as a start-up mentor for the NIH's Commercialization Assistance Program and works with UC-Davis's Entrepreneurship Academy and The Michael J. Fox Foundation’s Therapeutic Development Initiative. Adam previously served on the boards of Airmid and Viriome. He has been an author on over 20 publications in the fields of neurology and cognition.

Adam is a Kauffman Fellow. He completed his postdoctoral training in neurobiology at Stanford University School of Medicine. Adam received a Ph.D. from Yale University and a BA from the SUNY-Binghamton.